Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Promisemed Hangzhou Meditech Co OCF Margin %?
Promisemed Hangzhou Meditech CoBJSE:920069 18 OCF Margin % is 29.65% as of Jun. 2026, which is 16% below its 10-year median of 35.21. GuruFocus rates BJSE:920069 with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 813 Medical Devices & Instruments companies, Promisemed Hangzhou Meditech Co ranks better than 92.5% on this metric.
The historical rank and industry rank for Promisemed Hangzhou Meditech Co's OCF Margin % or its related term are showing as below:
BJSE:920069'
s OCF Margin % Range Over the Past 10 Years
Min: 24.14 Med: 35.21 Max: 44.97
Current: 29.38
During the past 4 years, the highest OCF Margin % of Promisemed Hangzhou Meditech Co was 44.97%. The lowest was 24.14%. And the median was 35.21%.
BJSE:920069's OCF Margin % is ranked better than 92.5% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: 6.64
vs BJSE:920069: 29.38
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promisemed Hangzhou Meditech Co OCF Margin % Chart
BJSE:920069 vs ISRG, BDX, RMD: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Promisemed Hangzhou Meditech Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promisemed Hangzhou Meditech Co OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Promisemed Hangzhou Meditech Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Promisemed Hangzhou Meditech Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promisemed Hangzhou Meditech Co (BJSE:920069) has a OCF Margin % of 29.65% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Promisemed Hangzhou Meditech Co and its competitors. This is 16% below median its historical median of 35.21. Over the past decade, Promisemed Hangzhou Meditech Co's OCF Margin % has ranged from 24.14 to 44.97. According to the industry distribution chart, Promisemed Hangzhou Meditech Co ranks #61 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 7.5%.
Is Promisemed Hangzhou Meditech Co's OCF Margin % too high?
Promisemed Hangzhou Meditech Co's current OCF Margin % of 29.65% is 16% below median its 10-year median of 35.21. Over the past 10 years, this metric has ranged from a low of 24.14 to a high of 44.97. The Medical Devices & Instruments industry median OCF Margin % is 6.64. Promisemed Hangzhou Meditech Co's value of 29.65% is 346.5% above this industry median. Based on the distribution chart, Promisemed Hangzhou Meditech Co ranks #61 out of 813 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Promisemed Hangzhou Meditech Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Promisemed Hangzhou Meditech Co's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Promisemed Hangzhou Meditech Co ranks #61 out of 813 companies for OCF Margin %. This places Promisemed Hangzhou Meditech Co in the top 8% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 6.64. Promisemed Hangzhou Meditech Co's value of 29.65% is 346.5% above this benchmark. Historically, Promisemed Hangzhou Meditech Co's own OCF Margin % has ranged from 24.14 to 44.97 over the past decade. While the company's 10-year median is 35.21 vs. the industry median of 6.64, Promisemed Hangzhou Meditech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.64, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Promisemed Hangzhou Meditech Co's current OCF Margin % of 29.65% is 346.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Promisemed Hangzhou Meditech Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promisemed Hangzhou Meditech Co's current OCF Margin % is 29.65%, which is 16% below median its own 10-year median of 35.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisemed Hangzhou Meditech Co stock overvalued right now?
Promisemed Hangzhou Meditech Co (BJSE:920069) has a current OCF Margin % of 29.65%. The current OCF Margin % is 29.65%, which is 16% below median its 10-year median of 35.21 and 346.5% above the Medical Devices & Instruments industry median of 6.64. Promisemed Hangzhou Meditech Co's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Promisemed Hangzhou Meditech Co (BJSE:920069), the current OCF Margin % is 29.65% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Promisemed Hangzhou Meditech Co Ltd is engaged in the Research, development, production and sales of diabetes care, universal drug delivery and infusion, and minimally invasive interventional medical devices.
18GF Score
Get the complete analysis for BJSE:920069
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920069 has been successfully added to your 
